Real-time Perspectives on the Transition to eSource: SCDM Best Practice Consensus Recommendations for Implementation and Scalability

The transition from traditional to modern data collection, in the form of eSource, has spawned an entire new ecosystem of approaches and vendors. This has created a complex web of considerations that leave many clinical research stakeholders unsure of where to start. A study from the Society of Clinical Data Management (SCDM) eSource Implementation Consortium, published in Contemporary Clinical Trials Communications in December 2024, found there were 36 steps research sites needed to traverse before they could even get started with eSource- all of which were associated with their own challenges. 1 Scalable implementation relies on the clinical research ecosystem, in collaboration with regulators, coming together to overcome these barriers. To this end, SCDM hosted a series of workshops and meetings in 2024, bringing leading subject matter experts from across the clinical research ecosystem together to share their knowledge, insights, and case studies. The initiative included three working groups, which focused on site readiness, contract readiness, and technological readiness. They were followed by a roundtable discussion, which reviewed and discussed the working groups' findings, the challenges and, crucially, the potential solutions of eSource implementation. This document summarizes those talks and sets out a range of best practices, all aimed at building a consensus that can act as a foundation for the wide-scale adoption of eSource clinical trial data collection and transfer across the industry. 1 Cramer, A.E., King, L.S., et al (2024). Defining methods to improve eSource site start-up practices. Contemporary Clinical Trials Communications, 42, 101391.

Institutions

Publication Details

Journal
Journal of the Society for Clinical Data Management
Published
2025-08-15
DOI
https://doi.org/10.47912/jscdm.442
Primary Topic
Medical and Biological Sciences
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-time Perspectives on the Transition to eSource: SCDM Best Practice Consensus Recommendations for Implementation and Scalability

Journal of the Society for Clinical Data Management
Medical and Biological Sciences
article

Real-time Perspectives on the Transition to eSource: SCDM Best Practice Consensus Recommendations for Implementation and Scalability

article en

Abstract

The transition from traditional to modern data collection, in the form of eSource, has spawned an entire new ecosystem of approaches and vendors. This has created a complex web of considerations that leave many clinical research stakeholders unsure of where to start. A study from the Society of Clinical Data Management (SCDM) eSource Implementation Consortium, published in Contemporary Clinical Trials Communications in December 2024, found there were 36 steps research sites needed to traverse before they could even get started with eSource- all of which were associated with their own challenges. 1 Scalable implementation relies on the clinical research ecosystem, in collaboration with regulators, coming together to overcome these barriers. To this end, SCDM hosted a series of workshops and meetings in 2024, bringing leading subject matter experts from across the clinical research ecosystem together to share their knowledge, insights, and case studies. The initiative included three working groups, which focused on site readiness, contract readiness, and technological readiness. They were followed by a roundtable discussion, which reviewed and discussed the working groups' findings, the challenges and, crucially, the potential solutions of eSource implementation. This document summarizes those talks and sets out a range of best practices, all aimed at building a consensus that can act as a foundation for the wide-scale adoption of eSource clinical trial data collection and transfer across the industry. 1 Cramer, A.E., King, L.S., et al (2024). Defining methods to improve eSource site start-up practices. Contemporary Clinical Trials Communications, 42, 101391.

Journal of the Society for Clinical Data ManagementVol. 0(2)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Memorial Sloan Kettering Cancer Center (US), Astellas Pharma (Japan) (JP), Pfizer (United States) (US), Astellas Pharma (China) (CN), Pinnacle Clinical Research (US), Johnson & Johnson (Israel) (IL)
Openalex Percentile: Top 55%
Medical and Biological Sciences
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.